• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于筛查新生儿遗传性听力损失变异的多重 PCR 扩增子测序检测方法。

A multiplex PCR amplicon sequencing assay to screen genetic hearing loss variants in newborns.

机构信息

BGI College, Zhengzhou University, Zhengzhou, 450001, China.

School of Life Sciences, Zhengzhou University, Zhengzhou, 450001, China.

出版信息

BMC Med Genomics. 2021 Feb 27;14(1):61. doi: 10.1186/s12920-021-00906-1.

DOI:10.1186/s12920-021-00906-1
PMID:33639928
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7913202/
Abstract

BACKGROUND

Congenital hearing loss is one of the most common birth defects. Early identification and management play a crucial role in improving patients' communication and language acquisition. Previous studies demonstrated that genetic screening complements newborn hearing screening in clinical settings.

METHODS

We developed a multiplex PCR amplicon sequencing assay to sequence the full coding region of the GJB2 gene, the most pathogenic variants of the SLC26A4 gene, and hotspot variants in the MT-RNR1 gene. The sensitivity, specificity, and reliability were validated via samples with known genotypes. Finally, a pilot study was performed on 300 anonymous dried blood samples.

RESULTS

Of 103 samples with known genotypes, the multiplex PCR amplicon sequencing assay accurately identified all the variants, demonstrating a 100% sensitivity and specificity. The consistency is high in the analysis of the test-retest reliability and internal consistency reliability. In the pilot study, 12.3% (37/300) of the newborns were found to carry at least one pathogenic variant, including 24, 10, and 3 from the GJB2, SLC26A4, and MT-RNR1 gene, respectively. With an allele frequency of 2.2%, the NM_004004.6(GJB2):c.109G>A was the most prevalent variant in the study population.

CONCLUSION

The multiplex PCR amplicon sequencing assay is an accurate and reliable test to detect hearing loss variants in the GJB2, SLC26A4, and MT-RNR1 genes. It can be used to screen genetic hearing loss in newborns.

摘要

背景

先天性听力损失是最常见的出生缺陷之一。早期识别和管理对改善患者的沟通和语言习得能力至关重要。先前的研究表明,遗传筛查在临床环境中补充了新生儿听力筛查。

方法

我们开发了一种多重 PCR 扩增子测序分析方法,用于对 GJB2 基因的完整编码区、SLC26A4 基因的最常见致病性变异体以及 MT-RNR1 基因中的热点变异体进行测序。通过具有已知基因型的样本验证了敏感性、特异性和可靠性。最后,对 300 份匿名干血斑样本进行了试点研究。

结果

在 103 个具有已知基因型的样本中,多重 PCR 扩增子测序分析准确地识别了所有的变异体,显示出 100%的敏感性和特异性。在测试-再测试可靠性和内部一致性可靠性的分析中,一致性很高。在试点研究中,发现 12.3%(37/300)的新生儿携带至少一种致病性变异体,分别来自 GJB2、SLC26A4 和 MT-RNR1 基因的 24、10 和 3 个。在研究人群中,最常见的变异体是 NM_004004.6(GJB2):c.109G>A,其等位基因频率为 2.2%。

结论

多重 PCR 扩增子测序分析是一种准确可靠的检测 GJB2、SLC26A4 和 MT-RNR1 基因中听力损失变异体的方法。它可用于筛查新生儿遗传性听力损失。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ad1/7913202/89a2c4ddcd23/12920_2021_906_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ad1/7913202/a4b2cdccce84/12920_2021_906_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ad1/7913202/7dbef42d7e39/12920_2021_906_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ad1/7913202/89a2c4ddcd23/12920_2021_906_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ad1/7913202/a4b2cdccce84/12920_2021_906_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ad1/7913202/7dbef42d7e39/12920_2021_906_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ad1/7913202/89a2c4ddcd23/12920_2021_906_Fig3_HTML.jpg

相似文献

1
A multiplex PCR amplicon sequencing assay to screen genetic hearing loss variants in newborns.一种用于筛查新生儿遗传性听力损失变异的多重 PCR 扩增子测序检测方法。
BMC Med Genomics. 2021 Feb 27;14(1):61. doi: 10.1186/s12920-021-00906-1.
2
Large scale newborn deafness genetic screening of 142,417 neonates in Wuhan, China.中国武汉对 142417 例新生儿进行大规模耳聋基因筛查。
PLoS One. 2018 Apr 10;13(4):e0195740. doi: 10.1371/journal.pone.0195740. eCollection 2018.
3
Newborn hearing concurrent genetic screening for hearing impairment-a clinical practice in 58,397 neonates in Tianjin, China.新生儿听力与遗传性听力障碍联合筛查——中国天津58397例新生儿的临床实践
Int J Pediatr Otorhinolaryngol. 2013 Dec;77(12):1929-35. doi: 10.1016/j.ijporl.2013.08.038. Epub 2013 Sep 8.
4
Genetic screening of newborns for deafness over 11 years in Beijing, China: More infants could benefit from an expanded program.中国北京对新生儿进行超过 11 年的耳聋基因筛查:更多婴儿将受益于扩大项目。
Biosci Trends. 2024 Sep 16;18(4):303-314. doi: 10.5582/bst.2024.01178. Epub 2024 Aug 25.
5
A rapid method for simultaneous screening of multi-gene mutations associated with hearing loss in the Korean population.一种用于快速筛选与韩国人群听力损失相关的多种基因突变的方法。
PLoS One. 2013;8(3):e57237. doi: 10.1371/journal.pone.0057237. Epub 2013 Mar 1.
6
Genetic screening of 15 hearing loss variants in 77,647 neonates with clinical follow-up.对 77647 例有临床随访的新生儿进行 15 种听力损失变异的基因筛查。
Mol Genet Genomic Med. 2024 Jan;12(1):e2324. doi: 10.1002/mgg3.2324. Epub 2023 Dec 1.
7
The mutation frequencies of GJB2, GJB3, SLC26A4 and MT-RNR1 of patients with severe to profound sensorineural hearing loss in northwest China.中国西北地区重度至极重度感音神经性听力损失患者的GJB2、GJB3、SLC26A4和MT-RNR1基因突变频率
Int J Pediatr Otorhinolaryngol. 2020 Sep;136:110143. doi: 10.1016/j.ijporl.2020.110143. Epub 2020 May 28.
8
Suspension array-based deafness genetic screening in 53,033 Chinese newborns identifies high prevalence of 109 G>A in GJB2.对53033名中国新生儿进行基于悬浮阵列的耳聋基因筛查,发现GJB2基因中109 G>A的高流行率。
Int J Pediatr Otorhinolaryngol. 2019 Nov;126:109630. doi: 10.1016/j.ijporl.2019.109630. Epub 2019 Aug 7.
9
Newborn genetic screening for high risk deafness-associated mutations with a new Tetra-primer ARMS PCR kit.使用新型四引物扩增阻滞突变系统聚合酶链反应试剂盒进行高危耳聋相关突变的新生儿基因筛查。
Int J Pediatr Otorhinolaryngol. 2013 Sep;77(9):1440-5. doi: 10.1016/j.ijporl.2013.05.040. Epub 2013 Jun 29.
10
Concurrent newborn hearing and genetic screening of common hearing loss variants with bloodspot-based targeted next generation sequencing in Jiangxi province.江西省采用基于血斑的靶向新一代测序技术对新生儿进行听力与常见听力损失变异基因的同步筛查。
Front Pediatr. 2022 Oct 31;10:1020519. doi: 10.3389/fped.2022.1020519. eCollection 2022.

引用本文的文献

1
Comparison of clinical performance of MeltPro hearing loss assay and targeted next generation sequencing assay for genetic screening of hearing loss.MeltPro听力损失检测与靶向新一代测序检测在听力损失基因筛查中的临床性能比较。
Sci Rep. 2025 Jul 2;15(1):22630. doi: 10.1038/s41598-025-06744-w.
2
Rapid detection of the c.235delC mutation based on CRISPR-Cas13a combined with lateral flow dipstick.基于CRISPR-Cas13a与侧向流动试纸条相结合的c.235delC突变的快速检测
Open Life Sci. 2025 Mar 11;20(1):20251064. doi: 10.1515/biol-2025-1064. eCollection 2025.
3
Association Between Expanded Genomic Sequencing Combined With Hearing Screening and Detection of Hearing Loss Among Newborns in a Neonatal Intensive Care Unit.

本文引用的文献

1
The mutational constraint spectrum quantified from variation in 141,456 humans.从 141456 名人类个体的变异中量化的突变约束谱。
Nature. 2020 May;581(7809):434-443. doi: 10.1038/s41586-020-2308-7. Epub 2020 May 27.
2
Concurrent hearing and genetic screening in a general newborn population.对一般新生儿群体进行同时的听力和遗传筛查。
Hum Genet. 2020 Apr;139(4):521-530. doi: 10.1007/s00439-020-02118-6. Epub 2020 Jan 30.
3
Concurrent Hearing and Genetic Screening of 180,469 Neonates with Follow-up in Beijing, China.中国北京对 180469 例新生儿进行了听力与遗传联合筛查及随访
扩展基因组测序联合听力筛查与新生儿重症监护病房新生儿听力损失检出的相关性。
JAMA Netw Open. 2022 Jul 1;5(7):e2220986. doi: 10.1001/jamanetworkopen.2022.20986.
4
Comprehensive genetic testing improves the clinical diagnosis and medical management of pediatric patients with isolated hearing loss.全面的基因检测可提高孤立性听力损失患儿的临床诊断和医学管理水平。
BMC Med Genomics. 2022 Jun 27;15(1):142. doi: 10.1186/s12920-022-01293-x.
5
The effect of hemolysis on quality control metrics for noninvasive prenatal testing.溶血对无创产前检测质量控制指标的影响。
BMC Med Genomics. 2022 Jun 4;15(1):125. doi: 10.1186/s12920-022-01280-2.
6
Molecular Genetic Screening of Neonatal Intensive Care Units: Hyperbilirubinemia as an Example.新生儿重症监护病房的分子遗传学筛查:以高胆红素血症为例。
Appl Clin Genet. 2022 May 18;15:39-48. doi: 10.2147/TACG.S362148. eCollection 2022.
7
NeoSeq: a new method of genomic sequencing for newborn screening.NeoSeq:一种用于新生儿筛查的基因组测序新方法。
Orphanet J Rare Dis. 2021 Nov 18;16(1):481. doi: 10.1186/s13023-021-02116-5.
Am J Hum Genet. 2019 Oct 3;105(4):803-812. doi: 10.1016/j.ajhg.2019.09.003. Epub 2019 Sep 26.
4
Comprehensive genetic testing of Chinese SNHL patients and variants interpretation using ACMG guidelines and ethnically matched normal controls.采用 ACMG 指南和与种族匹配的正常对照对中国感音神经性听力损失患者进行全面的基因检测和变异解读。
Eur J Hum Genet. 2020 Feb;28(2):231-243. doi: 10.1038/s41431-019-0510-6. Epub 2019 Sep 20.
5
We must now put in place an updated, comprehensive newborn screening program for deaf and hard-of-hearing infants.我们现在必须建立一个针对失聪和听力障碍婴儿的更新后的全面新生儿筛查项目。
Genet Med. 2019 Nov;21(11):2439-2441. doi: 10.1038/s41436-019-0638-3. Epub 2019 Aug 15.
6
A proposal for comprehensive newborn hearing screening to improve identification of deaf and hard-of-hearing children.全面新生儿听力筛查提案,以改善聋儿和重听儿童的发现。
Genet Med. 2019 Nov;21(11):2614-2630. doi: 10.1038/s41436-019-0563-5. Epub 2019 Jun 7.
7
Consensus interpretation of the p.Met34Thr and p.Val37Ile variants in GJB2 by the ClinGen Hearing Loss Expert Panel.ClinGen 听力损失专家小组对 GJB2 中 p.Met34Thr 和 p.Val37Ile 变异的共识解读。
Genet Med. 2019 Nov;21(11):2442-2452. doi: 10.1038/s41436-019-0535-9. Epub 2019 Jun 4.
8
A rapid improved multiplex ligation detection reaction method for the identification of gene mutations in hereditary hearing loss.一种用于遗传性听力损失基因突变鉴定的快速改良多重连接依赖性探针扩增反应方法。
PLoS One. 2019 Apr 11;14(4):e0215212. doi: 10.1371/journal.pone.0215212. eCollection 2019.
9
Nationwide population genetic screening improves outcomes of newborn screening for hearing loss in China.全国人口遗传筛查提高了中国新生儿听力损失筛查的结果。
Genet Med. 2019 Oct;21(10):2231-2238. doi: 10.1038/s41436-019-0481-6. Epub 2019 Mar 20.
10
Prevalence of mutations in the GJB2, SLC26A4, GJB3, and MT-RNR1 genes in 103 children with sensorineural hearing loss in Shaoxing, China.中国绍兴103例感音神经性听力损失儿童中GJB2、SLC26A4、GJB3和MT-RNR1基因突变的发生率
Ear Nose Throat J. 2018 Jun;97(6):E33-E38. doi: 10.1177/014556131809700603.